Main factors of gender dimorphism of gout (estrogens and diuretics vs alcohol and genetics)
- 作者: Barskova V.1, Eliseev M.1, Chikalenkova N.2, Barskova V3, Eliseev M3, Chikalenkova N4
-
隶属关系:
- Научно-исследовательский институт ревматологии РАМН
- Главный военный клинический госпиталь внутренних войск МВД РФ
- Research Institute of Rheumatology, AMS, Moscow
- Central hospital of the Ministry of Internal Affairs, Moscow
- 期: 卷 83, 编号 5 (2011)
- 页面: 57-61
- 栏目: Editorial
- URL: https://journals.rcsi.science/0040-3660/article/view/30862
- ID: 30862
如何引用文章
全文:
详细
关键词
作者简介
Viktoriya Barskova
Научно-исследовательский институт ревматологии РАМН
Email: barskova@irramn.ru
д-р мед. наук, проф., рук. лаб. микрокристаллических артритов НИИР РАМН; Научно-исследовательский институт ревматологии РАМН
Maksim Eliseev
Научно-исследовательский институт ревматологии РАМН
Email: elicmax@rambler.ru
канд. мед. наук, ст. науч. сотр. лаб. микрокристаллических артритов НИИР РАМН; Научно-исследовательский институт ревматологии РАМН
Nailya Chikalenkova
Главный военный клинический госпиталь внутренних войск МВД РФ
Email: nailygaaskerova@mail.ru
врач-ревматолог Главного военного клинического госпиталя внутренних войск МВД РФ; Главный военный клинический госпиталь внутренних войск МВД РФ
V Barskova
Research Institute of Rheumatology, AMS, MoscowResearch Institute of Rheumatology, AMS, Moscow
M Eliseev
Research Institute of Rheumatology, AMS, MoscowResearch Institute of Rheumatology, AMS, Moscow
N Chikalenkova
Central hospital of the Ministry of Internal Affairs, MoscowCentral hospital of the Ministry of Internal Affairs, Moscow
参考
- Насонова В. А., Барскова В. Г. Ранние диагностика и лечение подагры - научно обоснованное требование улучшения трудового и жизненного прогноза больных. Науч.-практ. ревматол. 2004; 1: 5-7.
- Adams P. F., Hendershot G. E., Marano M. A. Current estimates from the National Health Interview Survey, 1996. - Vital Health Stat 10, 1999.
- Lawrence R. C., Helmick C. G., Arnett F. C. et al. Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. Arthr. and Rheum. 1998; 41: 778- 799.
- Saag K. G., Mikuls T. R. Recent advances in the epidemiology of gout. Curr. Rheumatol. Rep. 2005; 7: 235-241.
- Roubenoff R., Klag M. J., Mead L. A. et al. Incidence and risk factors for gout in white men. J. A. M. A. 1991; 266: 3004- 3007.
- Terkeltaub R. A. Clinical practice. Gout. N. Engl. J. Med. 2003; 349: 1647-1655.
- Wallace K. L., Riedel A. A., Joseph-Ridge N., Wortmann R. Increasing prevalence of gout and hyperuricemia over 10 years among older adult in a managed care population. J. Rheumatol. 2004; 31: 1582-1587.
- Kramer H. M., Curhan G. The association between gout and nephrolitiasis: the National and Nutrition Examination Survey III, 1988-1994. Am. J. Kidney Dis. 2002; 40: 37-42.
- Annemans L., Spaepen E., Gaskin M. et al. Gout in the UK and Germany: prevalence, comorbidities and management in general practice 2000-2005. Ann. Rheum. Dis. 2008; 67: 960-966.
- Arromdee E., Michet C. J., Crowson C. S. et al. Epidemiology of gout: Is the incidence rising? J. Rheumatol. 2002; 29: 2403-2406.
- Bhole V., de Vera M., Rahman M. M., Krishnan E., Choi H. Epidemiology of gout in women: Fifty-two-year followup of a prospective cohort. Arthr. and Rheum. 2010; 62(4): 1069- 1076.
- Campion E. W., Glynn R. J., DeLabry L. O. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am. J. Med. 1987; 82: 421-426.
- Lally E. V., Ho G., Kaplan S. R. The clinical spectrum of gouty arthritis in women. Arch. Intern. Med. 1986; 146(11): 2221-2225.
- ALLHAT officers and Coordinators for the ALLHAT Collaborative Research Group. Major cardiovascular events in hypertensive patients randomized to doxazosin vs chlorthalidone: the antihypertensive and lipid-lowering treatment to preventheart attack trial (ALLHAT). J. A. M. A. 2000; 283: 1967-1975.
- Chobanian A. V., Bakris G. L., Black H. R. et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. J. A. M. A. 2003; 289: 2560-2572.
- Lin K. C., Lin H. Y., Chou P. The interaction between uric acid level and other risk factors on the development of gout among asymptomatic hyperuricemic men in a prospective study. J. Rheumatol. 2000; 27: 1501-1505.
- St. Onge M. P., Keller K. L., Heymsfield S. B. Changes in childhood food consumption patterns - a cause for concern in light of increasing body weight. Am. J. Clin. Nutr. 2003; 78: 1068-1073.
- Bieber J. D., Terkeltaub R. A. Gout. On the brink of a novel therapeutic options for an ancient disease. Arthr. and Rheum. 2004; 50: 2400-2414.
- Reyes D., Lew S. Q., Kimmel P. L. Gender differences in hypertension and kidney disease. Med. Clin. N. Am. 2005; 89: 613-630.
- Harrold L. R., Yood R., Mikuls T. R. et al. Sex differences in gout epidemiology: evaluation and treatment. Ann. Rheum. Dis. 2006; 65(10): 1368-1372.
- Nicholls A., Scott J. T. Effect of weight-loss on plasma and urinary levels of uric acid. Lancet 1972; 2: 1223-1224.
- Sumino H., Ichikawa S., Kanda T. et al. Reduction of serum uric acid by hormone replacement therapy in postmenopausal women with hyperuricaemia. Lancet 1999; 354: 650.
- Nicholls A., Snaith M. L., Scott J. T. Effect of oestrogen therapy on plasma and urinary levels of uric acid. Br. Med. J. 1973; 1: 449-451.
- Simon J. A., Lin F., Vittinghoff E., Bittner V. The relation of postmenopausal hormone therapy to serum uric acid and the risk of coronary heart disease events: the heart and estrogen-Progestin replacement Study (HERS). Ann. Epidemiol. 2006; 16: 138-145.
- Mikkelsen W. M., Dodge H. J., Valkenburg H. The distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan, 1959-1960. Am. J. Med. 1965; 39: 242-251.
- Strasaak A. M., Kelleher C. C., Brant L. J. et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: a prospective 21-year follow-up study. Int. J. Cardiol. 2008; 125: 232-239.
- Hak A. E., Choi H. K. Menopause, postmenopausal hormone use and serum uric acid levels in US women - The Third National Health and Nutrition Examination Survey. Arthr. Res. Ther. 2008; 10(5): R116.
- Choi H. K., Curhan G. Beer, liquor, wine and serum uric acid level -- the Third National Health and Nutrition Examination Survey. Arthr. and Rheum. 2004; 51(6): 1023-1029.
- Sharpe C. R. A case-control study of alcohol consumption and drinking behavior on patients with acute gout. Can. Med. Assoc. J. 1984; 131: 563-567.
- Drum D. E., Goldman P. A., Jankowski C. B. Elevation of serum uric acid as a clue to alcohol abuse. Arch. Intern. Med. 1981; 141: 477-479.
- Faller J., Fox I. H. Ethanol-induced hyperuricemia: evidence for increased urate production by activation of adenine nucleotide turnover. N. Engl. J. Med. 1982; 307: 1598-1602.
- Puig J. G., Fox I. H. Ethanol-induced activation of adenine nucleotide turnover. Evidence for a role of acetate. J. Clin. Invest. 1984; 74: 936-941.
- Eastmond C. J., Garton M., Robins S., Riddoch S. The effects of alcoholic beverages on urate metabolism in gout sufferers. Br. J. Rheumatol. 1995; 34: 756-759.
- Gibson T., Rodgers A. V., Simmonds H. A., Toseland P. Beer drinking and its effect on uric acid. Br. J. Rheumatol. 1984; 23: 203-209.
- Halla J. T., Ball G. V. Saturnine gout: a review of 42 patients. Semin. Arthr. and Rheum. 1982; 11: 307-314.
- Lin J. L., Huang P. T. Body lead stores and urate excretion in men with chronic renal disease. J. Rheumatol. 1994; 21: 705- 709.
- Kaneko K., Fujimori S., Akaoka I. Changes caused by ethanol intake on metabolism of hypouricemic agents (combination of allopurinol and benzbromarone). Adv. Exp. Med. Biol. 1991; 309: 139-142.
- Ralston S. H., Calpell H. A., Sturrock R. D. Alcohol and response to treatment of gout. Br. Med. J. 1988; 296: 1641- 1642.
- Puig J. G., Michan A. D., Jimenez M. L. et al. Female gout. Clinical spectrum and uric acid metabolism. Arch. Intern. Med. 1991; 51(4): 726-732.
- Snaith M. Gout and alcohol. Rheumatology 2004; 43: 1208- 1209.
- Rehm J., Greenfield T. K., Rogers J. D. Average volume of alcohol consumption, pattern of drinking, and all-cause mortality: results from the US National Alcohol Survey. Am. J. Epidemiol. 2001; 153: 64-71.
- Holman C. D., English D. R., Milne E., Winter M. G. Meta-analysis of alcohol and all-cause mortality: a validation of NHMRC recommendations. Med. J. Aust. 1996; 164: 141-145.
- Snow W. M., Murray R., Ekuma O. et al. Alcohol use and cardiovascular health, outcomes: a comparison across age and gender in the Winnipeg health and drinking survey cohort. Age and Ageing 2009; 38: 206-212.
- Hall A. P., Barry P. E., Dawber T. R. et al. Epidemiology of gout and hyperuricemia: A long-term population study. Am. J. Med. 1967; 42: 27-37.
- American Heart Association. 2002 Heart and stroke statistical update. Dallas, Texas: American Heart Association; 2001.
- Turner R. E., Frank M. J., Van Ausdal D. et al. Some aspects of the epidemiology of gout. Arch. Intern. Med. 1960; 106: 400-406.
- Williamson J., Chopin J. M. Adverse reactions to prescribed drugs in the elderly: a multicentre investigation. Age and Ageing 1980; 9: 73-80.
- van Kraaij D. J. W., Jansen R. W., de Gier J. J. et al. Prescription patterns of diuretics in Dutch community-dwelling elderly patients. Br. J. Clin. Pharmacol. 1998; 46: 403-407.
- Nath S. D., Voruganti V. S., Arar N. H. et al. Genome scan for determinants of serum uric acid variability. J. Am. Soc. Nephrol. 2007; 18: 3156-3163.
- Yang Q., Guo C. Y., Cupples I. A. et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart study. Metabolisms 2005; 54: 1435-1441.
- Terkeltaub R., Bushinsky D. A., Becker M. A. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthr. Res. Ther. 2006; 8(Suppl. 1): S4.
- Mount D. B., Kwon C. Y., Zandi-Nejad K. Renal urate transport. Rheum. Dis. Clin. N. Am. 2006; 32: 313-331.
- Anzai N., Kanai Y., Endou H. New insights into renal transport of urate. Curr. Opin. Rheumatol. 2007; 19: 151-157.
- Graessler J., Graessler A., Unger S. et al. Association of the human urate transporter 1 with redued renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthr. and Rheum. 2006; 54: 292-300.
- Vazquez-Mellado J., Jimenez-Vaca A. L., Cuevas-Covarrubias S. et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007; 46: 215-219.
- Ichida K., Hosoamada M., Hisatome I. et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 2004; 15: 164-173.
- Augustin R., Carayannopoulos M. O., Dowd L. O. et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT-9): alternative slicing alters trafficking. J. Biol. Chem. 2004; 279: 16229-16236.
- Brandstatter A., Kleichl S., Kollerits B. et al. Sex-Specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabet. Care 2008; 31(8): 1662-1667.